#460: Why healthtech still hasn't had its big exits

<p>This week, James is joined by Dr Sai Narimetla, an A&amp;E doctor who simultaneously works in investment banking at SSG Capital, to ask why healthtech hasn&#39;t produced the exits that biotech and medical devices have. They get into fragmentation, why the deals that are happening don&#39;t make headlines, and what a clinical lens actually adds when you&#39;re diligencing a company.</p><p><br></p><p>Connect with Sai: <a href="https://www.linkedin.com/in/sainarimetla/" target="_blank" rel="ugc noopener noreferrer">https://www.linkedin.com/in/sainarimetla/</a></p><p>Learn more about SSG Capital: <a href="https://www.ssgcapital.uk/" target="_blank" rel="ugc noopener noreferrer">https://www.ssgcapital.uk/</a></p><p><br></p><p>Apply to be a guest: https://www.thehealthtechpodcast.com</p><p>Subscribe to Healthtech Pigeon: https://www.healthtechpigeon.com</p><p>Get in touch with James: https://www.jamessomauroo.com</p><p><br></p><p>This podcast was brought to you by SomX.</p><p><br></p>